Dr. Reddy's Laboratories, Indian pharmaceuticals

Dr. Reddy's Laboratories Stock - weekly outlook with earnings ahead

19.06.2026 - 16:32:19 | ad-hoc-news.de

Dr. Reddy's Laboratories enters the week with its next earnings date already on the calendar and Indian market pricing near intraday lows. The article tracks the schedule, the latest quote, and the core business behind the stock.

Dr. Reddy's Laboratories, Indian pharmaceuticals, Friday earnings calendar
Dr. Reddy's Laboratories, Indian pharmaceuticals, Friday earnings calendar

Edited by ad hoc news Friday Desk. Verified prior to publication on 06/19/2026, 16:29 UTC. Details in the imprint.

Dr. Reddy's Laboratories (INE089A01031) enters Friday with its next earnings date already on the calendar. Market data services point to July 22, 2026, for the company's next quarterly update.

Go deeper

All news and analysis on Dr. Reddy's Laboratories stock

See the latest coverage, price data, and company background in one place.

What market data shows

Live quote pages show Dr. Reddy's shares at around ?1,265.65 on the BSE, with a slight daily decline on 06/19/2026. The same service listed the day's range at ?1,261.10 to ?1,271.30 and updated the quote at 13:28 on Friday.LiveMint market page

The Economic Times also tracked the stock near ?1,265.00 to ?1,275.90 during the session. That left the shares modestly lower, with traders focused on the next results date rather than a fresh corporate announcement.Economic Times live blog

Friday's calendar view

For a Friday article, the relevant angle is the week's setup into earnings. MarketBeat's estimate page points to 07/22/2026 as the next earnings date, giving investors a clear calendar marker before the quarter lands.

That matters because Dr. Reddy's often draws attention from retail and institutional investors when results are close. The schedule gives the stock a fixed event window, even before any guidance or margin commentary appears.

What the company sells

Dr. Reddy's is an Indian pharmaceutical group with a broad portfolio of branded generics, generic medicines, and active pharmaceutical ingredients. Upstox says the company produces more than 190 medications and more than 60 active pharmaceutical ingredients.

That mix matters for revenue visibility. It also makes the company a play on prescription volumes, regulatory filings, and supply-chain execution, not just on one product line.

Where the shares trade

The shares of Dr. Reddy's Laboratories Ltd. (INE089A01031) trade on the BSE at about ?1,265.65 as of 06/19/2026, 13:28 UTC.

Key facts on Dr. Reddy's Laboratories stock

  • Company: Dr. Reddy's Laboratories Ltd.
  • ISIN: INE089A01031
  • Ticker: DRREDDY
  • Venue: BSE
  • Price (as of 06/19/2026, 13:28 UTC): ?1,265.65
  • Sector / Industry: Biotechnology & Drugs
  • Next earnings date: 07/22/2026

More on Dr. Reddy's Laboratories stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | boerse | 69583375 |